Growth Hormone

CJC-1295 + Ipamorelin

Name: CJC-1295 + Ipamorelin
Brand: North Summit Labs
SKU: NSL-CJCIPA-10
Price: 64.99 USD
Availability: InStock

Combination blend commonly researched for growth hormone secretagogue pathways and recovery models.

Available Strengths

Buy More, Save More

Multi-vial deal: Buy 2, save 2% · 3, save 3% · 4, save 5% · 5+, save 10% on the same item, on top of the sale price (applied automatically in your cart).

Published COA · 10mg

View lot-specific COA

Lot: CA-20263
Lab: Analytical Formulations, Inc.
Report issued: October 12, 2026
Result: All tests passed assay

Tests performed on this lot: CJC-1295 · Ipamorelin · Heavy Metals · TAMC · TYMC

Contact for Order

Third-Party Analysis

Lot CA-20263 COA published

All tests passed assay

Per published report

Ships Nationwide

All 50 states

Peptide Calculator — reconstitution & syringe units

Work out Laboratory Dilutent Solution volume, mg/mL concentration, and exact insulin-syringe units for CJC-1295 + Ipamorelin.

Customer Reviews

About CJC-1295 + Ipamorelin

This blend combines CJC-1295 (no DAC), a GHRH analog, with Ipamorelin, a selective ghrelin-receptor secretagogue, in a single vial intended for combined-pathway research on growth hormone secretagogue signaling.

Laboratories studying pulsatile GH release, secretagogue receptor selectivity, and downstream IGF-1 pathway markers frequently use this blend format to reduce the number of separate reconstitution steps required for comparative dosing designs.

Lot documentation is shown on this product page: a published lot-specific COA where one is available, otherwise a COA on request.

Research Areas

Growth hormone secretagogue pathway research
Pulsatile GH release modeling
Ghrelin receptor selectivity studies
IGF-1 downstream marker research

Specifications

Form	Lyophilized powder
Quantity per vial	10mg total blend
Appearance	White lyophilized powder
SKU	NSL-CJCIPA-10

Storage & Handling

Store lyophilized vials at -20°C for long-term laboratory storage; short-term storage at 2–8°C is acceptable for materials in active use.
Protect vials from light and repeated freeze-thaw cycles; aliquot before freezing where practical.
Once a vial has been opened in a laboratory setting, use within the timeframe recommended by your institution's SOPs and document handling in your lab notebook.
Keep sealed vials in a desiccated environment; humidity exposure can degrade lyophilized peptide material over time.

Testing & Quality

Lots are submitted for independent third-party analysis. Methods vary by lot and are listed on each published COA; where no current COA is published, lot documentation is available on request.

CJC-1295 + Ipamorelin 10mg · Lot CA-20263

Analytical Formulations, Inc. · Issued October 12, 2026

CJC-1295 · Ipamorelin · Heavy Metals · TAMC · TYMC

Learn more on our Testing & Quality page or browse the COA library.

Research reference

CJC-1295 is a long-acting GHRH analog and ipamorelin is a selective ghrelin-receptor (GHS-R1a) agonist. Each has published pharmacology; the fixed combination itself has no dedicated controlled clinical trial.

Read the CJC-1295 / Ipamorelin research overview

Shipping & Returns

Free U.S. shipping on orders over $200; otherwise a flat $9.99 shipping rate applies. All sales are final.See our full Shipping & Returns policy for details.

Frequently Asked Questions

What is the ratio of CJC-1295 to Ipamorelin?

The vial contains a combined 10mg blend; component split is documented on the lot's COA.

Is this a DAC or no-DAC formulation of CJC-1295?

This blend uses CJC-1295 without DAC. The exact per-vial content of the lot you receive is stated on its certificate of analysis.

Is a COA available for this blend?

Where a current lot-specific COA is published, it is linked on this product page with its lot number, lab, test date, and methods. Otherwise, contact us and documentation can be provided on request.